07 Jul 2021 / 13:21 H.
Bernama
KUALA LUMPUR: Malaysian firm Yong Tai Bhd, which has partnered China-based Shenzhen Kangtai Biological Products Co. Ltd. (SZKT) to supply Chinese-produced Covid-19 vaccine in Malaysia, is targeting to offer its vaccines to private sector by September or October.
Yong Tai's chief executive officer Boo Kuang Loon said the group, which has an agreement with SZKT to supply 10 million doses per year with an additional option of 10 million if required, has commenced its trial vaccination.
“We are currently conducting the Phase III Clinical Trial in Malaysia and have made an application to the National Pharmaceutical Regulatory Agency for approval to use the vaccines here. If everything goes smooth, we aim to obtain the approval by September or October,“ he told Xinhua in a recent written interview.